STOCK TITAN

IART CFO Lea Daniels Knight uses 5,226 shares to satisfy tax obligations

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INTEGRA LIFESCIENCES HOLDINGS CORP Executive Vice President and Chief Financial Officer Lea Daniels Knight reported a routine tax-related share disposition. On this Form 4, 5,226 shares of common stock were withheld at $18.05 per share to satisfy tax obligations, leaving her with 45,263 directly held shares.

Positive

  • None.

Negative

  • None.
Insider Knight Lea Daniels
Role EVP & Chief Financial Officer
Type Security Shares Price Value
Tax Withholding Common Stock 5,226 $18.05 $94K
Holdings After Transaction: Common Stock — 45,263 shares (Direct, null)
Footnotes (1)
Tax-withholding shares 5,226 shares Shares delivered to satisfy tax liability
Tax-withholding price $18.05 per share Value used for tax-withholding disposition
Shares held after transaction 45,263 shares Direct common stock holdings post-transaction
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Knight Lea Daniels

(Last)(First)(Middle)
1100 CAMPUS ROAD

(Street)
PRINCETON NEW JERSEY 08540

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/03/2026F5,226D$18.0545,263D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Lesha Shinn; Attorney-in-Fact for Lea Knight07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did IART CFO Lea Daniels Knight report?

Lea Daniels Knight reported a tax-withholding disposition of 5,226 IART common shares. The shares were withheld by the company to cover tax liabilities, rather than sold in the open market, and are recorded as a Form 4 transaction.

Was the IART insider transaction an open-market sale of shares?

No, the transaction was not an open-market sale. It was a tax-withholding disposition, where 5,226 shares were delivered at $18.05 per share to satisfy tax obligations, a common mechanism tied to equity compensation events.

How many INTEGRA LIFESCIENCES (IART) shares does the CFO hold after this filing?

After the tax-withholding disposition, the CFO directly holds 45,263 IART common shares. This figure reflects her remaining position following the delivery of 5,226 shares to cover tax liabilities associated with equity compensation.

What does transaction code F mean in the IART Form 4 filing?

Transaction code F indicates payment of exercise price or tax liability by delivering securities. In this case, 5,226 IART common shares were used to satisfy tax obligations, rather than being sold in a discretionary market transaction.

Does the IART Form 4 show any insider share purchases or sales?

The Form 4 does not show any open-market purchases or sales. It reports a single tax-withholding disposition (code F) for 5,226 shares, used to pay tax liabilities, which is generally considered a routine administrative equity event.